Literature DB >> 11434714

Diversion of prescription drugs to the black market: what the states are doing to curb the tide.

D A Forgione1, P Neuenschwander, T E Vermeer.   

Abstract

The diversion of legitimate controlled substances to the black market is a major cause of medical emergencies, fatalities, and drug-related dependencies. The effects harm not only the illegal user, but also the legitimate patient who may be getting shorted on treatments and innocent medical providers who may be charged with false claim offenses or other professional failures because of diversions that take place during their watch. The dollar magnitude of this crime is estimated to rival the black markets for both crack cocaine and heroine combined. This article addresses the various ways prescription drugs are diverted to the black market, some monitoring programs employed by the states, and guidelines that doctors, pharmacists, and other providers can use to protect themselves against possible liabilities arising from the diversion of prescription drugs. We will also address some of the oppositions to monitoring programs that have been asserted and replies to these oppositions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11434714

Source DB:  PubMed          Journal:  J Health Care Finance        ISSN: 1078-6767


  9 in total

1.  Prescription Drug Abuse & Diversion: Role of the Pain Clinic.

Authors:  Khary K Rigg; Samantha J March; James A Inciardi
Journal:  J Drug Issues       Date:  2010

2.  Beyond abuse and exposure: framing the impact of prescription-medication sharing.

Authors:  Richard C Goldsworthy; Nancy C Schwartz; Christopher B Mayhorn
Journal:  Am J Public Health       Date:  2008-04-29       Impact factor: 9.308

3.  Adolescent athletes and the demand and supply of drugs to improve their performance.

Authors:  Patrick Laure; Caroline Binsinger
Journal:  J Sports Sci Med       Date:  2005-09-01       Impact factor: 2.988

4.  Prescription medication borrowing among adult patients at an urban medical center.

Authors:  Lawrence Ward; Nima M Patel; Alexandra Hanlon; Shaden Eldakar-Hein; Kristin Sherlinski; Stephanie H Ward
Journal:  J Urban Health       Date:  2011-12       Impact factor: 3.671

5.  Mechanisms of prescription drug diversion among drug-involved club- and street-based populations.

Authors:  James A Inciardi; Hilary L Surratt; Steven P Kurtz; Theodore J Cicero
Journal:  Pain Med       Date:  2007-03       Impact factor: 3.750

6.  The "black box" of prescription drug diversion.

Authors:  James A Inciardi; Hilary L Surratt; Theodore J Cicero; Steven P Kurtz; Steven S Martin; Mark W Parrino
Journal:  J Addict Dis       Date:  2009-10

7.  Investigation of systems to prevent diversion of opiate drugs in general practice in the UK.

Authors:  R Baker; P Moss; D Upton; J Pankhania
Journal:  Qual Saf Health Care       Date:  2004-02

8.  Prevalence of borrowing and sharing prescription medicines and associated socio-demographic factors: findings from COBERS health centres in northern Uganda.

Authors:  James Henry Obol; Peter Akera; Pamela Ochola Atim; Sylvia Awor; Ronald Wanyama; Kenneth Luryama Moi; Bongomin Bodo; Patrick Olwedo Odong; Emmanuel Otto Omony; Hussein Oria; David Musoke; Felix Kaducu
Journal:  BMC Pharmacol Toxicol       Date:  2018-04-18       Impact factor: 2.483

9.  Detecting drug diversion in health-system data using machine learning and advanced analytics.

Authors:  Tom Knight; Bernie May; Don Tyson; Scott McAuley; Pam Letzkus; Sharon Murphy Enright
Journal:  Am J Health Syst Pharm       Date:  2022-08-05       Impact factor: 2.980

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.